We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
–
AUM
$21.1M
AUM Growth
–
Cap. Flow
+$17.6M
Cap. Flow %
83.49%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BRNS
Barinthus Biotherapeutics
BRNS
+$9.5M
2
HOWL icon
Werewolf Therapeutics
HOWL
+$8.07M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRNS
1
Barinthus Biotherapeutics
BRNS
$22.8M
$10.8M 51.19%
+642,204
New +$9.5M
HOWL icon
2
Werewolf Therapeutics
HOWL
$17.2M
$10.3M 48.81%
+589,102
New +$8.07M

Similar funds

HGCK
HPC Germany & Co KG Potsdam, Germany $1.48M AUM 24.97% 1-Year Est. Return
DILIH
Dai-ichi Life International Holdings Tokyo, Japan $1.52M AUM
SH
Svenska Handelsbanken Stockholm, Sweden $1.38M AUM 61.04% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $1.33M AUM
SCM
SVB Capital Management Menlo Park, California $2.07M AUM 23.37% 1-Year Est. Return
AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
HB
Huntington Bancshares Columbus, Ohio $777K AUM
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return

DC Funds's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for DC Funds, which disclosed 2 positions worth $21.1M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Barinthus Biotherapeutics: 642,204 shares worth $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • DC Funds's largest Q2 2021 buy was Barinthus Biotherapeutics: 642,204 shares worth $10.8M.
  • DC Funds's ten largest holdings make up 100% of its $21.1M portfolio in Q2 2021.
  • DC Funds disclosed 2 positions in Q2 2021, its first 13F filing on record.

Based on DC Funds's 13F filing for Q2 2021, filed 13 Aug 2021.